Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (20%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SZPERKA, MICHAEL EDWARD | 1 | 62.7% | +37.0% |
| FAUST, AMBER KATHLEEN | 1 | 60.3% | +53.6% |
| SHUPE, ELIZABETH A | 1 | 65.7% | +46.8% |
| LIU, SUE XU | 1 | 20.8% | +17.0% |
| MOLOYE, TITILAYO | 1 | 63.2% | +47.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17820804 | INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES | LIU, SUE XU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17848320 | COMBINATORIAL CANCER IMMUNOTHERAPY | MOLOYE, TITILAYO | 29d overdue |
| 18504037 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | SZPERKA, MICHAEL EDWARD | — |
| 18201596 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | FAUST, AMBER KATHLEEN | — |
| 18199154 | INDUCIBLE CELL DEATH SYSTEMS | SHUPE, ELIZABETH A | — |
| 17820804 | INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES | LIU, SUE XU | — |
| Art Unit | Apps |
|---|---|
| 1643 | 2 |
| 1641 | 1 |
| 1616 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18504037 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | SZPERKA, MICHAEL EDWARD | 1641 | §112DP | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18201596 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | FAUST, AMBER KATHLEEN | 1643 | §102§112DP | Non-Final OA | — | Pending | May 24, 2023 |
| 18199154 | INDUCIBLE CELL DEATH SYSTEMS | SHUPE, ELIZABETH A | 1643 | DP | Non-Final OA | — | Pending | May 18, 2023 |
| 17820804 | INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES | LIU, SUE XU | 1616 | §102§103§112Other | Non-Final OA | — | Pending | Aug 18, 2022 |
| 17848320 | COMBINATORIAL CANCER IMMUNOTHERAPY | MOLOYE, TITILAYO | 1632 | Other | Final Rejection | 29d overdue | Pending | Jun 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial